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Abstract 
 The prolyl-4-hydroxylase domain (PHD) oxygen sensor proteins hydroxylate hypoxia-
inducible transcription factor (HIF) α-subunits, leading to their subsequent ubiquitinylation and 
degradation. Since oxygen is a necessary co-substrate, a reduction in oxygen availability 
(hypoxia) decreases PHD activity and subsequent HIFα hydroxylation. Non-hydroxylated HIFα 
cannot be bound by the ubiquitin ligase von Hippel-Lindau tumor suppressor protein and HIFα 
proteins thus become stabilized. HIFα then heterodimerizes with HIFβ to form the functionally 
active HIF transcription factor complex which targets approximately 200 genes involved in 
adaptation to hypoxia. The three HIFα prolyl-4-hydroxylases are clearly of different nature 
compared with the prototype collagen prolyl-4-hydroxylase which hydroxylates a mass protein 
rather than a rare transcription factor. Thus, novel assays had to be developed to express and 
purify functionally active PHDs and to measure PHD activity in vitro. There is also a need for 
such assays to functionally distinguish the three different PHDs in terms of substrate specificity 
and drug function. We provide a detailed description of the expression and purification of the 
PHDs, as well as of a HIFα-dependent and a ΗΙFα-independent PHD assay. 
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Introduction 
 Cells sense changes in environmental oxygen availability by a group of enzymes which 
directly control the cellular response to low oxygen by destabilizing hypoxia-inducible factor 
(HIF) α subunits, the master transcriptional regulators of the hypoxic response. These oxygen 
sensing enzymes have alternatively been termed prolyl-4-hydroxylase domain (PHD), HIF prolyl 
hydroxylase (HPH) or egg laying defective nine homolog (EGLN). Up to date, three family 
members are known: PHD1/HPH3/EGLN2, PHD2/HPH2/EGLN1 and PHD3/HPH1/EGLN3 
(Bruick, 2000; Epstein et al., 2001; Ivan et al., 2002). PHDs hydroxylate HIF-1α and HIF-2α at 
two distinct proline residues within the HIFα oxygen-dependent degradation (ODD) domain 
(Fig. 1A). Under normoxic conditions, prolyl-4-hydroxylation allows binding of the von Hippel-
Lindau tumor suppressor protein (pVHL), leading to polyubiquitinylation and proteasomal 
destruction (Schofield and Ratcliffe, 2004; Wenger, 2002). Under hypoxic conditions, prolyl-4-
hydroxylation is reduced, HIF-1α and HIF-2α become stabilized, heterodimerize with the 
constitutively expressed HIF-1β subunit aryl hydrocarbon receptor nuclear translocator (ARNT), 
and regulate the expression of a large number of effector genes involved in adaptation to low 
oxygen (Wenger et al., 2005). In addition, factor inhibiting HIF (FIH) hydroxylates an 
asparagine residue within the C-terminal transactivation domain. Oxygen-dependent asparagine 
hydroxylation blocks the recruitment of the CBP/p300 transcriptional co-activators and thereby 
regulates the transcriptional activity of HIFs (Hewitson et al., 2002; Lando et al., 2002; Mahon 
et al., 2001). 
 PHDs do not represent static oxygen sensor molecules but rather are highly regulated 
themselves. Importantly, PHD2 and PHD3, but not PHD1, have been reported to be hypoxically 
induced at both the mRNA and protein levels (Epstein et al., 2001). Accordingly, elevated PHD2 
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and PHD3 levels have been demonstrated in a broad panel of established cancer cell lines 
(Appelhoff et al., 2004). Functional hypoxia response elements (HREs) are located in the 
promoter region of the human PHD2 gene as well as in the first intron of the human PHD3 gene, 
demonstrating that PHD2 and PHD3 are HIF target genes themselves (Metzen et al., 2005; 
Pescador et al., 2005). Because the essential co-factor oxygen is basically lacking under hypoxic 
conditions, the HIF-dependent hypoxic increase in PHD abundance is somehow paradoxical and 
it has been suggested that PHD induction plays a role in accelerating the termination of the HIF 
response following re-oxygenation (Appelhoff et al., 2004; Aprelikova et al., 2004; Epstein et 
al., 2001; Marxsen et al., 2004). Indeed, biochemical in vitro studies revealed Km values of 
purified PHDs for oxygen close to the oxygen partial pressure (pO2) in air, suggesting that the 
kinetics of specific HIFα hydroxylation under hypoxic conditions are rather slow (Ehrismann et 
al., 2006; Hirsilä et al., 2003). Of note, these Km values are critically dependent on the length of 
the target peptide (Koivunen et al., 2006). However, tissues in situ have to deal with a great 
variability of generally very low pO2 values, even when the inspiratory pO2 is considered to be 
“normoxic”. We recently showed that HIF-dependent regulation of PHD levels adapts the PHD-
HIF oxygen sensing system to a given tissue pO2, rather than simply accelerating HIFα 
destruction following re-oxygenation (Stiehl et al., 2006). Such a self-regulatory loop might 
define a tissue-specific threshold for HIFα-activation as a function of local pO2.  
 In addition to transcriptional regulation, PHD levels are also regulated by protein-protein 
interactions: the ubiquitin ligase Siah2 regulates PHD1 and PHD3, but not PHD2, protein 
stability (Nakayama et al., 2004); PHD3, but not PHD1 or PHD2, appears to be a substrate for 
the TRiC chaperonin (Masson et al., 2004); OS-9 apparently is simultaneously interacting with 
both HIFα and PHD2 or PHD3, but not PHD1, thereby enhancing HIFα hydroxylation and 
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degradation (Baek et al., 2005); and Morg1 might provide the molecular scaffold for HIFα 
interaction specifically with PHD3 (Hopfer et al., 2006). On the other hand, PHD2 has been 
shown to inhibit the transactivation function of HIF-1α in VHL-deficient cells (To and Huang, 
2005), a process that might involve PHD2-dependent recruitment of ING4, a likely component 
of a chromatin-remodeling complex (Ozer et al., 2005). 
 These findings suggest two additional layers in oxygen signalling: first, abundance and 
function of PHDs actually can be regulated; and second, the three different PHDs are regulated 
in non-identical ways, further supporting their non-redundant roles in oxygen sensing. In fact, 
while all three PHDs can hydroxylate HIFα with similar efficiency in vitro, PHD2 has been 
suggested to play the main role for normoxic HIFα turnover in cultured cells (Berra et al., 2003). 
Consistent with these findings, PHD2 but neither PHD1 nor PHD3 knock-out mice die during 
embryonic development (Takeda et al., 2006). Interestingly, a family with erythrocytosis due to 
a mutation in the gene encoding PHD2 has recently been reported (Percy et al., 2006). The three 
PHDs are expressed in most organs but there are strikingly high levels of PHD3 and PHD1 
mRNA expressed in the heart and testis, respectively (Stiehl et al., 2006; Willam et al., 2006).  
 PHD function can also be regulated by a number of endogenous small molecules as well 
as by a number of clinically relevant drugs: ascorbate (Knowles et al., 2003), transition metals 
(Hirsilä et al., 2005; Martin et al., 2005), Krebs cycle intermediates (Dalgard et al., 2004; Lu et 
al., 2005; Selak et al., 2005) and reactive oxygen species (ROS) including NO (Berchner-
Pfannschmidt et al., 2006; Gerald et al., 2004; Metzen et al., 2003) have been shown to influence 
or completely block the activity of the PHDs. Thus, molecular cross-talks appear to exist 
between oxygen homeostasis and transition metal homeostasis as well as cellular metabolism. 
However, it is not completely understood how various transition metals and ascorbate interfere 
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with PHD and FIH function. The transition metals do not simply replace or oxidize the ferrous 
iron in the active center of the hydroxylases (Hirsilä et al., 2005; Martin et al., 2005). At least 
cobalt and nickel might deplete intracellular ascorbate (Karaczyn et al., 2006; Salnikow et al., 
2004). As known for collagen hydroxylation, ascorbate is essential to reduce ferric iron in the 
active center of PHDs and FIH which occurs when oxidative decarboxylation of 2-oxoglutarate 
is uncoupled from target hydroxylation (McNeill et al., 2005; Myllylä et al., 1984). 
 In addition to kinase signalling pathways, numerous reports appeared about an 
involvement of ROS in HIFα protein stabilization by either growth stimuli or hypoxia. Non-
conclusive data were obtained so far about the source(s) of the ROS and whether hypoxia leads 
to an increase or decrease in ROS levels (Wenger, 2000). However, ROS do have the potential to 
interfere with the complex process of protein hydroxylation. Indeed, the increase in ROS in 
junD-/- cells leads to a decrease in PHD activity and hence to HIF-1α accumulation (Gerald et 
al., 2004). Apart from direct interference of ROS with the active center of oxygen sensing 
protein hydroxylases, also the re-direction of oxygen from mitochondria towards the protein 
hydroxylases might contribute to these effects (Hagen et al., 2003; Wenger, 2006). 
 Due to the large therapeutical potential of PHD inhibitors in the treatment of anemic and 
ischemic diseases, several attempts to develop PHD antagonists are in progress. Currently, N-
oxyalylglycine (N-OG) and its cell-permeable derivative dimethyloxalylglycine (DMOG) are the 
commercially available PHD inhibitors of choice for experimental purposes. Apart from these 
co-substrate competitive inhibitors, iron chelators are very well known to induce HIF by PHD 
inhibition. These include desferoxamine (DFX) and ciclopirox olamine (CPX), two clinically 
relevant hydroxamic acid iron chelators (Linden et al., 2003). In order to functionally investigate 
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the potency and mechanisms of available and future PHD inhibitors, there is a clear need for 
reliable methods to generate PHD proteins and to determine their activity. 
 
Production of functionally active PHDs 
 Since bacterially expressed PHDs retain only little hydroxylase activity, PHDs were 
expressed and purified from baculovirally infected insect cells. To facilitate purification, the 
PHDs were tagged with either glutathione-S-transferase (GST), maltose-binding protein (MBP) 
or His6. According to our experience, best results were obtained with GST-tagged PHD proteins. 
Thus, GST-tagged expression vectors were prepared by LR clonase-mediated homologous 
recombination of the corresponding pENTR vector, containing PHD1, PHD2 or PHD3 cDNA 
inserts, with the pDEST20 vector (Invitrogen). Recombined plasmids were transfected into the 
E. coli strain DH10BAC and the resulting bacmid plasmids were used to generate baculovirus 
stocks according to the manufacturer's instructions (Invitrogen). Spodoptera frugiperda (Sf) 9 
cells were infected with baculovirus and cultured in Grace's insect medium (Invitrogen) at 27°C 
in a humidified incubator. Infected cells were grown for 80 to 110 hours, collected by 
centrifugation at 700 × g for 10 minutes at 4°C and washed with ice-cold PBS. Lysis was 
performed on ice for 10 minutes with 0.1% NP-40 in a buffer containing 10 mM Tris-HCl pH 
7.4, 100 mM NaCl, 100 mM glycine, 100 µM dithiothreitol (DTT) and EDTA-free complete 
protease inhibitor cocktail (Roche). Crude lysate was cleared by centrifugation at 20,000 × g for 
20 minutes at 4°C and the supernatant was incubated with glutathione-sepharose beads 
(previously washed with PBS) for at least 2 hours at 4°C with gentle agitation. After washing 
three times with PBS the protein was eluted with 15 mM reduced glutathione (GSH) in 50 mM 
Tris-HCl pH 8.0 and 2 µM FeSO4. Eluted proteins were supplemented with 5% glycerol and 
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stored in aliquots at -80°C. Purity was checked by SDS-PAGE followed by coomassie staining 
or immunoblotting (Fig. 1B). Activity was routinely determined by the VHL binding assay 
described below (Fig. 1C).  
 
Determination of prolyl-4-hydroxylation by VHL binding to peptides derived from the 
HIF-1α ODD domain 
 Enzymatic activities of recombinant PHD proteins were determined by an in vitro 
hydroxylation assay based on a 96-well format as described previously (Oehme et al., 2004). 
Briefly, biotinylated synthetic peptides derived from human HIF-1α amino acids 556 to 574 
(biotin-DLDLEALAPYIPADDDFQL), either wild-type, P564A mutant or hydroxylated 
(Hyp564), were bound to NeutrAvidin-coated 96-well plates (Pierce). All methionine residues 
were mutated to alanine residues in these peptides (M561A, M568A). Hydroxylase reactions 
using purified recombinant GST-tagged PHDs or cellular extracts were carried out for 1 hour at 
room temperature. A polycistronic bacterial expression vector for His6-tagged and thioredoxin-
tagged pVHL/elongin B/elongin C (VBC) complex (kindly provided by S. Tan, Pennsylvania, 
PA) was used to express VBC in E. coli strain BL21AI followed by purification using nickel 
affinity chromatography (GE Healthcare), followed by gel filtration. The VBC complex was 
allowed to bind to the hydroxylated peptides for 15 minutes, anti-thioredoxin antibodies were 
added for 30 minutes, and horseradish peroxidase-coupled anti-rabbit antibodies (Sigma) were 
added for 30 minutes. Bound VBC complex was detected using the TMB (3,3’,5,5’-
tetramethylbenzidine) substrate kit (Pierce). The peroxidase reaction was stopped by adding one 
volume 2 M H2SO4 and absorbance was determined at 450 nm in a microplate photometer. This 
assay is routinely used to determine the activity of the three GST-tagged PHD enzymes purified 
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from Sf9 insect cells (Fig. 1C). Inter-assay comparability was guaranteed by calibration of each 
experiment to an internal standard curve using increasing fraction of synthetic hydroxyproline-
containing peptides (Fig. 2A). When performed with pre-equilibrated solutions in a hypoxic 
glove box (Invivo2 400, Ruskinn Technology), this assay nicely demonstrates that PHD2 and 
PHD3 hydroxylase activities are functional over a wide range of physiologically relevant oxygen 
concentrations (Fig. 2B). Furthermore, this assay is strictly dependent on the presence of P564 
within the substrate peptide, and the iron chelator DFX as well as the substrate analog N-OG 
inhibit PHD-dependent prolyl-4-hydroxylation (Fig. 2C).  
 Apart from purified recombinant PHDs, also crude cellular extracts are suitable sources 
of PHD activity for the VBC binding assay. Therefore, Hep3B cells were lysed by dounce 
homogenization in 100 mM Tris-HCl pH 7.5, 1.5 mM MgCl2, 8.75% glycerol, 0.01% Tween20 
and EDTA-free complete protease inhibitor cocktail (Roche). Cell lysates were cleared by 
centrifugation at 20,000 × g for 30 minutes at 4°C. As shown in Fig. 2D, these extracts 
stimulated VBC binding to wild type but not P564A mutant HIF-1αODD-derived peptides. The 
specificity of the PHD activity was further demonstrated by inhibition with 2mM N-OG and by 
culturing the Hep3B cells under hypoxic conditions (0.4% O2 for 16 hours). Consistent with the 
known hypoxic induction of PHD2 and PHD3, extracts derived from hypoxic Hep3B cells 
showed an increased PHD activity (Fig. 2D). Similar results were obtained with HeLa cells (data 
not shown). 
 
Determination of prolyl-4-hydroxylation by oxidative decarboxylation of 2-oxoglutarate 
 While the VHL binding assay is well suited to investigate PHD function, it is strictly 
dependent on VBC binding and hence unlikely to investigate the hydroxylation of potential 
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novel non-HIFα targets. To overcome this problem, a 2-oxoglutarate to succinate conversion 
assay, originally developed to study collagen hydroxylation (Kaule and Günzler, 1990), was 
adapted to HIFα hydroxylation. There are basically two possibilities to label the 2-oxoglutarate 
co-substrate: when [5-14C]2-oxoglutarate is used, the resulting [14C]succinate can be measured 
(Kaule and Gunzler, 1990); when [1-14C]2-oxoglutarate is used, the resulting [14C]CO2 must be 
captured and quantified (Hirsilä et al., 2003). Because it is technically less demanding, the 
former technique is used in our laboratory. This assay was first applied for PHD measurements 
by Frelin and co-workers using "light mitochondrial rat kidney fractions" (D'Angelo et al., 2003; 
D'Angelo et al., 2003). We measured oxidative decarboxylation of 2-oxoglutarate by purified 
PHDs, because kidney extracts prepared according to Frelin and co-workers in fact solely 
showed high background activities, but did not contain measurable quantities of specific PHD 
activity (see below). Peptide (5-50 µM) or protein substrates (5 µM) were incubated with 0.1 µg 
GST-tagged PHD enzymes in 100 µl 50 mM Tris-HCl pH 7.4, 10 µM 2-oxoglutarate, 2 mM 
ascorbate, 100 µM DTT, 1 mg/ml BSA, 0.6 mg/ml catalase, 5 µM freshly prepared FeSO4 and 
50,000 - 100,000 dpm [5-14C]2-oxoglutarate with a specific activity of 50 mCi/mmol (Hartmann-
Analytic). The 2-oxoglutarate concentration can be varied from 10 to 100 µM, depending on the 
peptide/protein target concentration and the desired specific radioactivity. Generally, a 2-fold 
molar excess over the target concentration was used. Hydroxylation reactions were carried out 
for 24 hours at 37°C. To separate 2-oxoglutarate from succinate, 25 µl 20 mM succinate and 20 
mM 2-oxoglutarate were added and mixed by vortexing. Subsequently, 25 µl 0.16 M 2,4-
dinitrophenyl hydrazine in 30% HClO4 were added. After incubation at room temperature for 30 
minutes, 50 µl of 1 M 2-oxoglutarate was added to remove residual 2,4-dinitrophenyl hydrazine, 
and the reaction was allowed to proceed for another 30 minutes at room temperature. Following 
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centrifugation at 20,000 × g for 15 minutes at 4°C, 150 µl supernatant was carefully removed, 
mixed with 3 ml scintillation cocktail (PerkinElmer), and the amount of [14C]succinate was 
determined by liquid scintillation counting in a β-counter (TRI-CARB 2900TR, Packard).  
 As depicted in Fig. 3A, using recombinant GST-PHD2 this assay shows a linear 
relationship between the availability of a HIF-1α ODD domain-derived synthetic peptide 
substrate and [14C]succinate production in the range from 8 to 50 µM peptide. Below 5 µM, 
however, only background values were obtained. This assay is strictly dependent on the presence 
of 1 mM ascorbate as well as a peptide substrate containing the wild-type P564 (Fig. 3B). The 
lack of a substrate peptide or the mutation of the critical proline (P564A) results in background 
2-oxoglutarate conversion.  
 
Crude tissue extracts are not a suitable source of PHD activity for the 2-oxoglutarate 
conversion assay. 
 Earlier reports suggested the use of "light mitochondrial rat kidney fractions" as a source 
for PHD activity in this type of assay (D'Angelo et al., 2003; D'Angelo et al., 2003). We 
therefore prepared rat kidney extracts according to this protocol and tested them for PHD 
activity. As shown in Fig. 4A, 2-oxoglutarate conversion was indeed stimulated by these 
extracts. However, a very high background activity was also observed in the absence of the HIF-
1α ODD domain-derived peptide and the presence of the wild-type peptide stimulated 2-
oxoglutarate conversion only moderately. To ensure PHD-dependent 2-oxoglutarate conversion, 
ample amounts of the known PHD inhibitors DFX and N-OG (see Fig. 2C) or CuCl2 (Martin et 
al., 2005) were added to the reaction mix. Surprisingly, none of these PHD inhibitors blocked 2-
oxoglutarate conversion, whether the substrate peptide was present or not (Fig. 4A, left panel). 
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Moreover, the presence of a P564A mutant peptide stimulated 2-oxoglutarate conversion as well 
as the wild-type peptide (Fig. 4A, right panel). The P564A mutant peptide cannot be 
hydroxylated and shows no VBC complex binding after incubation with purified PHDs (Figs. 2C 
and 3B). Therefore, these experiments clearly demonstrate that "light mitochondrial rat kidney 
fractions" do not represent a source of specific PHD activity but rather contain high levels of 
enzymes unspecifically metabolising 2-oxoglutarate. A similar lack of specific (i.e. PHD-
dependent) 2-oxoglutarate conversion was observed with crude extracts derived from HeLa, 
Hep3B and Sf9 cells (data not shown). 
 
Thin layer chromatography to assess the purity of [5-14C]2-oxoglutarate 
 A major problem in the optimisation of the 2-oxoglutarate conversion method is the high 
proportion of background activity when non-purified PHD preparations are used as source of the 
enzymatic activity. Indeed, cellular extracts usually contain too high background activities to be 
suitable as PHD source, even when the PHDs are exogenously overexpressed. Another 
background-causing problem was the quality of the radioactively labelled [5-14C]2-oxoglutarate. 
To analyse the [5-14C]2-oxoglutarate preparations for impurities, it was diluted in 1.5 mM non-
labeled 2-oxoglutarate and spotted onto thin layer chromatography (TLC) plates (Silica gel 60 
F254, Merck). Following drying, the TLC plate was placed in a chromatography chamber 
containing a 120:70:15 mixture of diethyl ether/hexane/formic acid. When the eluent reached the 
top of the TLC plate, it was dried and the radioactivity quantitated by phosphorimaging 
(BioRad). Non-labeled 2-oxoglutarate and succinate were used as standards. They were 
visualized as bright yellow spots by immersing the TLC plates in a 0.04% bromcresol purple 
solution in a 1:1 mixture of ethanol and water (adjusted to pH 10.0 with NaOH) and dried with a 
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hair-dryer. Rf values for succinate and 2-oxoglutarate were 0.45 and 0.12, respectively. As 
shown in Fig. 4B, there are considerable differences in the quality of the available [5-14C]2-
oxoglutarate preparations. While some batches were of acceptable purity (Fig. 4B, left panel), 
others contained up to 30% of an impurity that co-migrated with the succinate standard (Fig. 4B, 
right panel). Regarding the relatively low specific PHD activities and the rather high unspecific 
background 2-oxoglutarate conversion, such high impurities are not acceptable in this type of 
assay. 
 
Application of the 2-oxoglutarate conversion assay to protein targets 
 In order to be useful for putative novel PHD substrate proteins without prior knowledge 
of the actual target prolyl residue, the 2-oxoglutarate conversion assay needs to work also with 
proteins rather than only with synthetic peptides. To demonstrate the feasibility of this approach, 
wild-type GST-HIF2αODD (aa 404-569, MW = 46 kDa) and P405A/P531A double-mutant 
GST-HIF2αODD protein fragments were expressed in E.coli BL21AI by induction with 0.2% 
arabinose for 4 hours at 37°C. After harvesting by centrifugation, the bacteria were lysed with a 
high pressure cell disrupter (Basic-Z, Constant Systems) in the prescence of EDTA-free 
complete protease inhibitor cocktail (Roche). Purification of the GST-tagged protein was carried 
out using affinity chromatography on glutathione sepharose beads (Amersham-GE Healthcare) 
as described above (see Fig. 1B). Purity of the recombinant protein fragments was checked by 
SDS-PAGE followed by coomassie staining or immunoblotting (Fig. 5A). When compared with 
a HIF-1αODD-derived wild-type peptide, equimolar concentrations of the HIF2αODD protein 
fragment also stimulated PHD1-dependent 2-oxoglutarate conversion, albeit to a somewhat 
lower extent (Fig. 5B). 
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Conclusions 
 The PHD-dependent hydroxylation assay presented here works independently of already 
known peptide sequences or VHL binding. It should thus be possible to use this assay for the 
investigation of putative novel, non-HIFα PHD substrates as well. In addition, even if not shown 
here, the same assay should principally also be applicable to novel FIH substrates and might 
become useful for screening for novel hydroxylation targets. Whereas no non-HIFα PHD 
hydroxylation targets have been reported thus far, FIH has recently been shown to hydroxylate a 
number of proteins containing ankyrin repeats, including NF-κB and IκBα (Cockman et al., 
2006). We expect a similar widening of the spectrum of PHD targets. In addition, PHD-
dependent hydroxylation assays will be required to study novel drugs that modulate PHD activity 
and hence will become important for the treatment of anemic and ischemic disease. 
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Figure legends 
FIG. 1. (A) Reaction mechanism of PHD-mediated oxygen-dependent prolyl-4-hydroxylation by 
oxidative decarboxylation of the co-substrate 2-oxoglutarate. Inhibitors of this reaction are 
indicated. N-OG, N-oxalylglycine; DMOG, dimethyloxalylglycine. (B) Purification of GST-
tagged PHD1, PHD2 and PHD3 expressed in baculovirus-infected Sf9 insect cells by glutathione 
affinity chromatography. The purified GST-PHD proteins were analyzed by SDS-PAGE and 
coomassie blue staining ("CBS") or immunoblotting ("IB") using anti-GST antibodies for the 
detection of GST-PHD1 and GST-PHD2 or anti-PHD3 antibodies for the detection of PHD3. (C) 
Hydroxylation activities of GST-PHD preparations determined by a VBC-binding assay as 
described in the text. Wild-type ("Pro") and P564A mutant ("Ala") HIF-1α ODD domain-derived 
peptides were used as hydroxylation substrates. 
 
FIG. 2. (A) VBC (pVHL/elongin B/elongin C) complex binding to prolyl-4-hydroxylated HIF-1α 
ODD domain-derived peptides. Biotinylated peptides containing increasing proportions of 
synthetically generated hydroxyproline peptides were allowed to bind to NeutrAvidin-coated 96 
well ELISA plates. Immunodetection of bound VBC complex was performed as described in the 
text. (B) Oxygen-dependent activity of recombinant GST-PHD2 and GST-PHD3. Purified PHD 
proteins were used to hydroxylate HIF-1α ODD domain-derived peptides under the indicated 
oxygen concentrations (% vol/vol in the gas phase). The extent of prolyl-4-hydroxylation was 
quantitated as described above. (C) PHD3 as well as the wild-type peptide substrate ("Pro") are 
required for VBC binding. The lack of peptide ("-"), a P564A mutation ("Ala"), iron chelation by 
desferrioxamine ("DFX") or N-oxalylglycine ("N-OG") all completely inhibited VBC binding. 
(A-C) Shown are mean values ± SEM of triplicates. (D) Hypoxia stimulates PHD activity in 
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Hep3B cells. Crude cellular lysates were used to hydroxylate HIF-1α ODD domain-derived 
peptides as described above. Shown are mean values ± SEM of triplicates normalized to protein 
content. 
 
FIG. 3. (A) Determination of prolyl-4-hydroxylation by oxidative decarboxylation of [5-14C]2-
oxoglutarate. Recombinant GST-PHD2 was incubated with increasing concentrations of a HIF-
1α ODD domain-derived peptide as indicated. PHD-dependent generation of [14C]succinate was 
determined as described in the text. Background activity was determined in control reactions 
without substrate peptide and the obtained value subtracted from the peptide-containing 
reactions. (B) Recombinant GST-PHD2 was incubated with increasing concentrations of 
ascorbate as indicated and either a wild-type, P564A mutant or no peptide substrate. 
 
FIG. 4. (A) Lack of specific 2-oxoglutarate-to-succinate conversion by "light mitochondrial rat 
kidney fractions". Left panel: peptide-stimulated activity in these extracts could not be inhibited 
by DFX, CuCl2 or N-OG. Right panel: a P564A mutant ("Ala") HIF-1α ODD domain-derived 
peptide stimulated 2-oxoglutarate conversion as well as the wild-type ("Pro") peptide. (B) 
Quality control of [5-14C]-2-oxoglutarate by thin layer chromatography. The amount of [5-14C]-
2-oxoglutarate spotted corresponded to 30 kdpm, 15 kdpm, 7.5 kdpm and 3.8 kdpm, respectively 
(from left to right). Two [5-14C]-2-oxoglutarate batches of different quality are shown. Pure 2-
oxoglutarate and succinate served as migration markers (positions indicated at the right margin).  
 
FIG. 5. (A) Purification of wild-type and P405/531A double mutant GST-HIF-2αODD (human 
HIF-2α amino acids 404-569) protein fragments expressed in bacteria and purified by 
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glutathione affinity chromatography. The purified proteins were analyzed by SDS-PAGE and 
coomassie blue staining ("CBS") or immunoblotting ("IB") using anti-GST antibodies. (B) 
Determination of prolyl-4-hydroxylation by oxidative decarboxylation of [5-14C]2-oxoglutarate. 
Recombinant GST-PHD1-dependent generation of [14C]succinate was promoted by HIF-
1αODD-derived wild-type ("wt") but not by P564A mutant ("mt") peptides (human HIF-1α 
amino acids 556-574). Generation of [14C]succinate was also promoted by wild-type GST-HIF-
2αODD protein but not by GST alone and to a much lower extent by the GST-HIF-2αODD 
P405/531A double mutant. Equimolar concentrations (5 µM) of the substrate peptides and 
protein fragments were used. Where indicated, the reactions could be blocked by 5 mM N-
oxalylglycine ("N-OG"). Shown are mean values ± SEM of three independent experiments 
performed in duplicates.  
 
